PRME
Prime Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.12
−0.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 56.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.22x
- Price / sales
- 138.94x
- Price / cash flow
- -3.63x
Enterprise value
- Enterprise value
- $583.3M
- EV / sales
- 143.21x
- EV / EBITDA
- -3.23x
- EV / EBIT
- -2.97x
- Market cap
- $565.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026